Vincent Cubelli is a Urologist in Denville, New Jersey. Dr. Cubelli is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are UPJ Obstruction, Enlarged Prostate (BPH), Obstructive Uropathy, Ureteroscopy, and Bladder Reconstruction. Dr. Cubelli is currently accepting new patients.

Gregg Zimmerman is a Urologist in Denville, New Jersey. Dr. Zimmerman is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Congenital Mesoblastic Nephroma, Enlarged Prostate (BPH), Perirenal Abscess, Vasectomy, and Reconstructive Urology Surgery. Dr. Zimmerman is currently accepting new patients.

William Rafelson, MD, MBA, is a fellowship-trained hematologist-oncologist with Atlantic Medical Group (AMG). Board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine, he has a focus in the management of advanced genitourinary cancers (cancers arising from the bladder, urinary tract, kidney, prostate, or testes), and treats a range of hematologic and oncologic disorders. He believes in providing compassionate care and uses a shared decision-making approach in tailoring the right treatment regimen, whether that is chemotherapy, hormone therapy, or immunotherapy to treat the patient’s disease.After earning his medical degree at the UMDNJ-Robert Wood Johnson Medical School at Camden, NJ, Dr. Rafelson completed an internal medicine residency at The Warren Alpert Medical School of Brown University, Providence, RI, served as a National Institutes of Health (NIH) T32 post-doctoral research fellow at Rhode Island Hospital, also in Providence, followed by fellowship in Hematology/Oncology, again at Warren Alpert School of Medicine. He also holds an MBA from the Heller School for Social Policy and Management, Brandeis University, Waltham, MA. Prior to joining AMG, he served as assistant attending in the Solid Tumor Genitourinary Oncology service at Memorial Sloan Kettering Cancer Center in Middletown, NJ, and served on the inpatient genitourinary service in Memorial Hospital in New York City.The author of multiple publications in peer-reviewed medical journals, Dr. Rafelson has also written several chapters in medical textbooks, including Ferri’s Clinical Advisor. He won a National Research Service Postdoctoral Award from the NIH and was one of just 15 medical oncologists nationally to be selected for a Rising Star Award from Castle Connolly. He was selected as one of “Jersey’s Best” medical oncologists in 2022 and 2023.Prior to joining AMG, Dr. Rafelson served as Instructor of Medicine and, later, Assistant Professor of Medicine at Weill Cornell Medical College, Cornell University, New York City, teaching first- and second-year medical students. He is a member of the American Society for Clinical Oncology and the American College of Physicians. He attends the MSKCC Annual Hematology-Oncology Review as well as ASCO annual conferences yearly to apply the most up-to-date information in his specialty. Dr. Rafelson is a participating provider of the Atlantic Accountable Care Organization. Dr. Rafelson is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer.

The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Prostatectomy, and Nephrectomy.

It’s important to me to connect with my patients on a personal level, which helps me better understand their problems and concerns. I’m genuinely interested in them and their families and improving their quality of life, and I encourage everyone in the practice to treat patients with that same level of compassion. My patients perceive me as an experienced, compassionate urologic surgeon they can rely on. I enjoy treating the entire range of urologic disorders, with a special interest in oncology and kidney problems. Dr. Taylor is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

My experience as a fellowship-trained urologic oncologist has taught me that optimizing medical care is a combination of incorporating evidence-based practices with a strong multidisciplinary team. I have always had deep compassion for patients as well as a curiosity about the science behind disease diagnosis, treatment, and prevention. There is great potential to both cure and improve the quality of life for patients with urologic disease. My training with leaders in the field of open and robotic surgery, pharmacotherapy, and integrative treatments has given me a dynamic toolset to address all of a patient’s needs. I offer minimally invasive surgery for a wide variety of malignant and benign urologic conditions to help patients recover quickly and allow them to spend more time on things that matter to them. Dr. Taylor is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Nephrectomy, and Ureteroscopy.

Naveed Jan is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Jan is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, and Vitamin B12 Deficiency. Dr. Jan is currently accepting new patients.

Christopher Tully is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Tully is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Lung Cancer. Dr. Tully is currently accepting new patients.

Jason Levitz is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Levitz is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is currently accepting new patients.

Neil Freeman is a Radiologist in Denville, New Jersey. Dr. Freeman is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Stroke, Bone Marrow Aspiration, and Splenectomy.

Francis Diaz is a Radiologist in Denville, New Jersey. Dr. Diaz is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Vertigo, and Pleurisy.

Fazal Bari is a Hematologist and an Oncologist in Mountain Lakes, New Jersey. Dr. Bari is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Colorectal Cancer. Dr. Bari is currently accepting new patients.

Dr. Saman Moazami knows that in the field of urology, individuals present with very intimate concerns that are complicated and at times difficult to talk about. His goal and his philosophy are centered on working together with his patients to solve these problems, while also serving as a source of psychosocial support. Dr. Moazami trained in a busy New York City tertiary care center, which has given him the exposure and tools necessary to handle complex patient conditions, while providing the highest level of care and expertise. Dr. Moazami is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Kidney Stones, Obstructive Uropathy, Hydronephrosis, Ureteroscopy, and Vasectomy.

I like to inform and educate my patients to include them in the decision process and intervene only when necessary. I will be facile and choose what’s best for the patient according to the circumstances while listening for the answer — it’s usually in the complaint — and being compassionate. Dr. Kaynan is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are UPJ Obstruction, Urinary Tract Infection in Children, Hydronephrosis, Reconstructive Urology Surgery, and Ureteroscopy.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Eric Whitman is a General Surgeon and a Surgical Oncologist in Morristown, New Jersey. Dr. Whitman is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Melanoma, Pancreatic Cancer, Hyperparathyroidism, and Familial Pancreatic Cancer.

Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Starker is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

Dr. Pressler always strives to provide compassionate and personalized care for all of his patients. He is a recognized regional expert in urologic oncology and robotic surgery. Dr. Pressler has the most experience using the da Vinci robot in northwest NJ. Dr. Pressler specializes in robotic prostatectomy, cystectomy, partial, nephrectomy and urinary tract reconstruction. He is the only urologist in NJ to perform neobladder reconstruction entirely robotic/laparoscopically. Dr. Pressler is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Hydronephrosis, Obstructive Uropathy, Prostate Cancer, Ureteroscopy, and Bladder Reconstruction.

I have been blessed to have received some of the finest urologic training available in the United States. My teachers and mentors at Cornell and Harvard have influenced me to simply be the best physician, surgeon, and person that I can be. I love my profession and cherish the opportunity to help the people of my community every day that I am in the office, hospital or operating room. I strive to treat every patient I see as if they were a family member and feel that a compassionate and individualized approach to health care is paramount in achieving the finest outcomes for my patients.Dr. Sutaria is one of the region’s top Robotic and minimally invasive surgeons and has trained other surgeons in the use of the Robotic Technology. Dr. Sutaria is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Obstructive Uropathy, Kidney Stones, Boils, Ureteroscopy, and Bladder Reconstruction.

My goal is to make lasting improvements in my patients’ lives and be the go-to guy who is respected for solving the most complex urologic problems. This way, patients and doctors can turn to me knowing I can tackle their urologic needs no matter how big or small. I chose urology because it involves a wide array of surgical problems while allowing me to maintain long-term relationships with patients. I get great satisfaction helping my patients understand their problems. It is important to be able to discuss and offer all treatment options available, both surgical and nonsurgical. If surgery is necessary, I offer the latest, least invasive techniques to return you to your normal life more quickly. Dr. Steinberg is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Hydronephrosis, Ureteroscopy, and Reconstructive Urology Surgery.